No Change in Huntington's Motor Symptoms With Investigational Drug
Laquinimod shows reduced caudate volume loss versus placebo in phase II study
Stay updated with breaking news from Total Functional Capacity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Laquinimod shows reduced caudate volume loss versus placebo in phase II study
~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to an inclusion criteria-matched natural...
~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to an inclusion criteria-matched natural...
Lessons learned from investigational tominersen
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for...